Related content

Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer

By Bonate Peter   Cunningham Casey   Gaynon Paul   Jeha Sima   Kadota Richard   Lam Gilbert   Razzouk Bassem   Rytting Michael   Steinherz Peter   Weitman Steve  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 875-890

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib inhibition of fludarabine uptake in T-lymphocytes

By Woodahl Erica   Wang Joanne   Heimfeld Shelly   Ren Aaron   McCune Jeannine  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 735-739

Springer Publishing Company

Access to resources Recommend Favorite

Melatonin metabolite excretion among cellular telephone users

By Burch J. B.   Reif J. S.   Noonan C. W.   Ichinose T.   Bachand A. M.   Koleber T. L.   Yost M. G.  

International Journal of Radiation Biology, Vol. 78, Iss. 11, 2002-11 ,pp. : 1029-1036

Informa Healthcare

Access to resources Recommend Favorite

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

By Bolton Ann   Peng Bin   Hubert Martine   Krebs-Brown Axel   Capdeville Renaud   Keller Urs   Seiberling Michael  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 102-106

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat

By Lu Hong   Chan Kenneth  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 532-539

Springer Publishing Company

Access to resources Recommend Favorite